Manuel Cobo

thumb Manuel Cobo Vega (born 18 June 1956) is a Spanish People's Party (PP) politician.

He served in the Assembly of Madrid from 1991 to 2003, where he was finance minister. He followed his mentor Alberto Ruiz-Gallardón into the local politics of Madrid, as a member of the city council from 2003 to 2012. He was deputy mayor and briefly acting mayor of the city. Following ill health and a double lung transplant, he returned to politics in 2023 as a member of the Congress of Deputies. Provided by Wikipedia
Showing 1 - 20 results of 38 for search 'Manuel Cobo', query time: 0.21s Refine Results
  1. 1
    Universidad y ética profesional
    by Juan Manuel COBO SUERO
    Published 2009-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    La educación para la ciudadanía en España desde la LODE y la LOGSE al Anteproyecto de LOE. Algunas propuestas para la programación y los profesores
    by Juan Manuel Cobo Suero
    Published 2019-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Prevalencia y severidad de la disfunción intestinal inducida por opioides
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Anexo
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis.
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Androgens contribute to sex differences in myocardial remodeling under pressure overload by a mechanism involving TGF-β.
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Revisión de la publicación de la información obligatoria en detergentes del Distrito Sanitario Jaén Sur
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Revisión de la publicación de la información obligatoria en detergentes del Distrito Sanitario Jaén Sur
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    595 Biomarker results from the 1st line non-small cell lung cancer cohort of TACTI-002: pharmacodynamic effects of combining eftilagimod alpha (soluble LAG-3) and pembrolizumab
    Article
    Save to List
    Saved in:
  18. 18
    Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Lung cancer symptoms at diagnosis: results of a nationwide registry study
    Get full text
    Article
    Save to List
    Saved in:
Search Tools: RSS Feed – Email Search